Elevated Levels of Circulating Interleukin-18 in Human Immunodeficiency Virus-Infected Individuals: Role of Peripheral Blood Mononuclear Cells and Implications for AIDS Pathogenesis
Open Access
- 15 December 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (24), 12448-12456
- https://doi.org/10.1128/jvi.76.24.12448-12456.2002
Abstract
Originally identified as the gamma interferon-inducing factor, interleukin-18 (IL-18) was rediscovered as a proinflammatory cytokine related to the IL-1 family of cytokines that plays an important role in both innate and adaptive immune responses against viruses and intracellular pathogens. Despite its importance in inducing and regulating immune responses, relatively little is known about its production in HIV infection. We report here significantly (P< 0.05) elevated levels of this cytokine in the sera of human immunodeficiency virus (HIV)-infected/AIDS patients compared to those of HIV-seronegative healthy persons. Surprisingly, the peripheral blood mononuclear cells (PBMC) from HIV-infected/AIDS patients were compromised in the ability to upregulate IL-18 gene expression and produce this cytokine with and without lipopolysaccharide (LPS) stimulation. A significant positive correlation (P< 0.05) existed between the concentration of IL-18 in serum and its production from PBMC of HIV-seronegative healthy individuals but not those of HIV-infected/AIDS patients. Furthermore, the patients' PBMC expressed relatively reduced levels of activated caspase-1 constitutively as well as in response to LPS stimulation. Our data suggest the involvement of transforming growth factor beta (TGF-β) in suppressing IL-18 production from the patients' PBMC for the following reasons. (i) In in vitro studies it suppressed the production of IL-18 from PBMC. (ii) Its levels were significantly higher in the plasma of patients compared to that of control subjects. (iii) A significant negative correlation existed between the concentrations of TGF-β in plasma and of IL-18 in serum of the patients. The elevated levels of IL-18 in the serum of HIV-infected individuals may contribute to AIDS pathogenesis, whereas its compromised production from their PBMC in response to stimuli may reduce their innate defense to opportunistic intracellular pathogens.Keywords
This publication has 49 references indexed in Scilit:
- Interleukin-18 Regulates Both Th1 and Th2 ResponsesAnnual Review of Immunology, 2001
- IL-18 underexpression reduces IL-2 levels during HIV infection: a critical step towards the faulty cell-mediated immunity?AIDS, 2000
- Interleukin 18 and Interleukin 1betaProduction Is Decreased in HIV Type 1-Seropositive Hemophiliacs but Not in HIV Type 1-Seropositive NonhemophiliacsAIDS Research and Human Retroviruses, 2000
- QUANTIFICATION OF HUMAN INTERLEUKIN 18 mRNA EXPRESSION BY COMPETITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTIONCytokine, 1999
- Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting EnzymeScience, 1997
- Molecular Analysis of Decreased Interleukin-12 Production in Persons Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Impaired interleukin 12 production in human immunodeficiency virus-infected patients.The Journal of Experimental Medicine, 1994
- TGFβ and HIV InfectionaAnnals of the New York Academy of Sciences, 1993